Principal Investigator
Peter Hosein
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250676
Clinical Trial Summary
A Phase 1a, Open-label, Multicenter, Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of KQB548 in Participants with Advanced Solid Malignancies with a KRAS G12D mutation
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Stomach and Esophageal Cancer
Contact Information
Phone Number
+1 (954) 8177628